PDT Partners’s Milestone Pharmaceuticals MIST Stock Holding History

PDT Partners’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,165	Closed	-$65K	–	1078
2022 Q1	$65K	Buy	+10,165	New	+$63.5K	0.01%	894

Other funds holding MIST

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

PDT Partners's MIST Position: Q2 2022 in Review

PDT Partners sold out of Milestone Pharmaceuticals (MIST) in Q2 2022, closing a stake of 10,165 shares — an estimated $65K sold.

PDT Partners first reported a position in MIST in Q1 2022 and held it in 1 quarter. The position peaked at $65K in Q1 2022. 29 funds tracked by Wall St. Rank hold MIST as of Q2 2022.

PDT Partners reported no remaining Milestone Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
PDT Partners sold 10,165 Milestone Pharmaceuticals shares in Q2 2022, an estimated $65K.
PDT Partners first reported a position in Milestone Pharmaceuticals in Q1 2022 and held it in 1 quarter.
PDT Partners's Milestone Pharmaceuticals position peaked at $65K in Q1 2022.
29 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.